Business JPMorgan initiates new coverage of Tenet Healthcare Overweight, PT $72.00 Nick J Adam Apr 19, 2023 JPMorgan initiates new coverage of Tenet Healthcare Overweight, PT $72.00 Stay connected with us on social media… Read More...
Business BMO Capital initiates new coverage of Canadian Pacific Railway Outperform Nick J Adam Apr 18, 2023 BMO Capital initiates new coverage of Canadian Pacific Railway Outperform Stay connected with us on social media… Read More...
Health Corcept Therapeutics Initiates CATALYST Clinical Trial James Pereira Mar 29, 2023 <!-- Name:DistributionId Value:8797160 --> <!--… Read More...
Gaming Gaming Innovation Group initiates strategic review for the purpose of separating the group into two… Kemal Pasha Feb 16, 2023 Reading Time: 3 minutes Deal allows free-to-play and daily fantasy sports specialist to offer its wide… Read More...
Health Aptose Initiates Dosing of Tuspetinib in APTIVATE Expansion Trial in Patients with Acute Myeloid… James Pereira Jan 30, 2023 <!-- Name:DistributionId Value:8738171 --> <!--… Read More...
Health Molecular Partners Initiates Clinical Study of Trispecific Candidate MP0533 for the Treatment of… James Pereira Jan 16, 2023 Unique avidity driven mechanism engages CD3 on T cells when binding either two or three tumor-associated antigens to… Read More...
Health Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi… James Pereira Jan 11, 2023 REYKJAVIK, Iceland, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing… Read More...
Business Kotak initiates coverage on this Tata stock. Should you buy? Nick J Adam Jan 6, 2023 Citing rich valuation, domestic brokerage firm Kotak Securities initiated coverage on with a reduce rating with a… Read More...
Business Sebi initiates study of fees, expenses charged by mutual funds Nick J Adam Dec 24, 2022 Capital markets regulator Sebi on Friday said it has initiated a detailed study of fees and expenses charged by mutual… Read More...
Health BridgeBio Pharma Initiates CALIBRATE, A Pivotal Phase 3 Study of Encaleret in Autosomal Dominant… James Pereira Dec 23, 2022 - The CALIBRATE Phase 3 study design incorporates feedback from global regulatory agencies and will compare the effects… Read More...